Occupational Therapists in Claremont, NH Accepting Medicare

11 Occupational Therapists found. Showing 1 - 11

Ms. Nicole Louise Allen, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Nursing Home Dr, Claremont, NH 03743 Phone: 603-542-9511

Kelly Winterbottom Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Nursing Home Dr, Claremont, NH 03743 Phone: 603-542-9511

Caroline Ward, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 243 Elm St, Claremont, NH 03743 Phone: 603-542-1878

Mr. Dorian Rodizza, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 290 Hanover St, Claremont, NH 03743 Phone: 603-542-2606

Mrs. Brian Johnson, COTA Occupational Therapist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 67 High St, Claremont, NH 03743 Phone: 603-558-8450

Susan Gaspard, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Ironwood Hill Rd, Claremont, NH 03743 Phone: 603-667-7865

Rebecca Anderson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 205 Maple Ave, Claremont, NH 03743 Phone: 603-499-5029

Holly Mitchell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 243 Elm St, Claremont, NH 03743 Phone: 603-542-1878    Fax: 603-542-1813

Tracy Keenan, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Nursing Home Dr, Claremont, NH 03743 Phone: 603-542-9511

Emma Waterhouse, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 165 Broad St, Claremont, NH 03743 Phone: 603-543-4200

Kaitlyn Lefebvre, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 210 Maple Ave, Claremont, NH 03743 Phone: 603-543-4200

News Archive

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.

New pain relievers reduce opiate overdose risk

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing-;the cause of opiate overdose.

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

Researchers explore wartime experiences and PTSD symptoms among female Air Force personnel

A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.

Read more Medical News

› Verified 5 days ago